Literature DB >> 29729218

Neonatal Growth Restriction Slows Cardiomyocyte Development and Reduces Adult Heart Size.

Madeline H Knott1, Sarah E Haskell1, Payton E Strawser1, Olivia M Rice1, Natalie T Bonthius1, Vani C Movva1, Benjamin E Reinking1, Robert D Roghair1.   

Abstract

Prematurity is associated with reduced cardiac dimensions and an increased risk of cardiovascular disease. While prematurity is typically associated with ex utero neonatal growth restriction (GR), the independent effect of neonatal GR on cardiac development has not been established. We tested the hypothesis that isolated neonatal GR decreases cardiomyocyte growth and proliferation, leading to long-term alterations in cardiac morphology. C57BL/6 mice were fostered in litters ranging in size from 6 to 12 pups to accentuate normal variation in neonatal growth. Regardless of litter size, GR was defined by a weight below the 10th percentile. On postnatal day 8, Ki67 immunoreactivity, cardiomyocyte nucleation status and cardiomyocyte profile area were assessed. For adult mice, cardiomyocyte area was determined, along with cardiac dimensions by echocardiography and cardiac fibrosis by Masson's trichrome stain. On day 8, cardiomyocytes from GR versus control mice were significantly smaller and less likely to be binucleated with evidence of persistent cell cycle activity. As adults, GR mice continued to have smaller cardiomyocytes, as well as decreased left ventricular volumes without signs of fibrosis. Neonatal GR reduces cardiomyocyte size, delays the completion of binucleation, and leads to long-term alterations in cardiac morphology. Clinical studies are needed to ascertain whether these results translate to preterm infants that must continue to grow and mature in the midst of the increased circulatory demands that accompany their premature transition to an ex utero existence. Anat Rec, 2018.
© 2018 Wiley Periodicals, Inc. © 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiac development; cardiomyocyte; growth; left ventricle; prematurity

Mesh:

Year:  2018        PMID: 29729218      PMCID: PMC6218323          DOI: 10.1002/ar.23851

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  49 in total

1.  Prenatal exposure to maternal undernutrition induces adult cardiac dysfunction.

Authors:  Kuljeet K Cheema; Melissa R Dent; Harjot K Saini; Nina Aroutiounova; Paramjit S Tappia
Journal:  Br J Nutr       Date:  2005-04       Impact factor: 3.718

2.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

3.  Influence of age, growth, and sex on cardiac myocyte size and number in rats.

Authors:  S L Bai; S E Campbell; J A Moore; M C Morales; A M Gerdes
Journal:  Anat Rec       Date:  1990-02

4.  Role of gender in morbidity and mortality of extremely premature neonates.

Authors:  Marie-Eve Binet; Emmanuel Bujold; Francine Lefebvre; Yves Tremblay; Bruno Piedboeuf
Journal:  Am J Perinatol       Date:  2011-08-04       Impact factor: 1.862

5.  Different functional cardiac characteristics observed in term/preterm neonates by echocardiography and tissue doppler imaging.

Authors:  Marco Matteo Ciccone; Pietro Scicchitano; Annapaola Zito; Michele Gesualdo; Marco Sassara; Grazia Calderoni; Federica Di Mauro; Grazia Ladisa; Antonio Di Mauro; Nicola Laforgia
Journal:  Early Hum Dev       Date:  2011-05-15       Impact factor: 2.079

6.  When early life growth restriction in rats is followed by attenuated postnatal growth: effects on cardiac function in adulthood.

Authors:  Vladislava Zohdi; James T Pearson; Michelle M Kett; Paul Lombardo; Michal Schneider; M Jane Black
Journal:  Eur J Nutr       Date:  2014-08-13       Impact factor: 5.614

7.  Intra-uterine growth restriction and the programming of left ventricular remodelling in female rats.

Authors:  Marie-Claude Battista; Ezequiel Calvo; Alzbeta Chorvatova; Blandine Comte; Jacques Corbeil; Michèle Brochu
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

8.  Timing of cardiomyocyte growth, maturation, and attrition in perinatal sheep.

Authors:  Sonnet S Jonker; Samantha Louey; George D Giraud; Kent L Thornburg; J Job Faber
Journal:  FASEB J       Date:  2015-07-02       Impact factor: 5.191

9.  Cardiovascular risk factors at age 30 following pre-term birth.

Authors:  Stuart R Dalziel; Varsha Parag; Anthony Rodgers; Jane E Harding
Journal:  Int J Epidemiol       Date:  2007-04-27       Impact factor: 7.196

10.  Neonatal growth restriction-related leptin deficiency enhances leptin-triggered sympathetic activation and central angiotensin II receptor-dependent stress-evoked hypertension.

Authors:  Veronica Peotta; Kamal Rahmouni; Jeffrey L Segar; Donald A Morgan; Kate M Pitz; Olivia M Rice; Robert D Roghair
Journal:  Pediatr Res       Date:  2016-04-06       Impact factor: 3.756

View more
  2 in total

1.  Postnatal Growth Restriction in Mice Alters Cardiac Protein Composition and Leads to Functional Impairment in Adulthood.

Authors:  Joseph R Visker; Lawrence J Dangott; Eric C Leszczynski; David P Ferguson
Journal:  Int J Mol Sci       Date:  2020-12-12       Impact factor: 5.923

2.  Hypersensitivity of Zebrafish htr2b Mutant Embryos to Sertraline Indicates a Role for Serotonin Signaling in Cardiac Development.

Authors:  Mitchell E Kent; Bo Hu; Timothy M Eggleston; Ryan S Squires; Kathy A Zimmerman; Robert M Weiss; Robert D Roghair; Fang Lin; Robert A Cornell; Sarah E Haskell
Journal:  J Cardiovasc Pharmacol       Date:  2022-08-01       Impact factor: 3.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.